Some studies have demonstrated that the overexpression of CMTM3 in pancreatic carcinoma was correlated with high recurrence, distant metastasis rate, low pathological grade, and poor survival times [15]. Here, CMTM3 is linked to exocrine pancreatic carcinoma.